Features of pahogocytic activity of monocytes and neutrophils in patients with obesity and ankylosinig spondylitis depending on HLA B27 gene carrier

Main Article Content

V.Yu. Hayevska


Background. Ankylosing spondylitis (AS) is a widespread pathology all over the world. The AS prevalence in different countries ranges from 0.2 to 2 %. Usually the disease debuts at the age of 20–40 years, men suffer from this patho­logy 6–9 times more often than women. Materials and methods. We observed 68 patients with acute stage. The general laboratory  and AS-specific testing were done for all patents, namely clinical blood analysis with leucogram (%, g/l), ESR, C-reactive protein, proteingram, for HIV carrier, for HCV and HBV specific antibodies and HLA B27 carrie. Results. AS patients with HLAB27 antigene had enhanced spontaneous and physiologic output of neutrophils and physiologic output of monocytes. Conclusions. Oxidative output can serve as an early predictor of autoimunne process in human.

Article Details

How to Cite
Hayevska, V. “Features of Pahogocytic Activity of Monocytes and Neutrophils in Patients With Obesity and Ankylosinig Spondylitis Depending on HLA B27 Gene Carrier”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 13, no. 3, June 2017, pp. 215-8, doi:10.22141/2224-0721.13.3.2017.104122.
To Endocrinologist from Other Expert


Belenkiy AG. Entezopathy in seronegative spondiloarthitis. Consilium Medicum. 2010;10. (In Russian).

Bekhterev VM. Numbness of back bone with curvature of himas is the special form of disease. Vrach. 1892;36:899-903. (In Russian).

Khaitov RM, Ilyuna NI. Allergology and Immunology. National Guidelines. Мoscow: GEОТАR-Media; 2009. 656 p. (In Russian).

Dagfinrud H, et al. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev. 2008 Jan 23;1: CD002822. doi: 10.1002/14651858.CD002822.pub3.

Svintsitskiy AS, Yaremenko OB, Puzanova OG, Khomchenkova NI. Rheumatological disease and syndromes. Кyiv: Knyga plius; 2006. pp. 285-94 (In Ukrainian).

Braun J, Davis J, Dougados M, et al. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2014;65:316-20. doi: 10.1136%2Fard.2005.040758.

Zochling J, Braun J, van der Heijde D. Assessments in ankylosing spondylitis. Best Pract Res Clin Rheumatol. 2011;20(3):521-37. doi: 10.1016/j.berh.2006.03.011.